Therefore, given the simplicity of saliva collection, detecting the soluble ACE2 in oral fluids may serve as an early tool for assessing population immunity and vaccine response, and it is particularly relevant as a potential non-invasive biomarker for predicting vaccine efficacy in vulnerable individuals (such as those with periodontitis) or when blood collection is not feasible. This evidence concerns the gene ACE2 and periodontitis.